_id
69148e33ccc777a4e85d9b0e
Ticker
PLLWF
Name
Polarean Imaging plc
Exchange
PINK
Address
27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://polarean.com
Description
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Last Close
0.0066
Volume
-
Current Price
0.0066
Change
0
Last Updated
2026-01-06T09:17:04.727Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
7966416
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
629826
Cost Of Revenue
534044
Gross Profit
95782
Operating Expenses
5695806
Operating Income
-5600024
Interest Expense
13908
Pretax Income
-5366148
Net Income
-5366148
Eps
-0.004445735098887923
Dividends Per Share
-
Shares Outstanding
1207032781
Income Tax Expense
-
EBITDA
-5110036
Operating Margin
-889.1382699348709
Total Other Income Expense Net
233875
Cash
7290630
Short Term Investments
-
Receivables
349395
Inventories
2255260
Total Current Assets
9895286
Property Plant Equipment
612857
Total Assets
11093291
Payables
2499274
Short Term Debt
135306
Long Term Debt
-
Total Liabilities
3188407
Equity
7904884
Bs_currency_symbol
USD
Depreciation
242205
Change In Working Capital
-750913
Cash From Operations
-5130245
Capital Expenditures
41119
Cash From Investing
-41120
Cash From Financing
-80514
Net Change In Cash
-4808505
Cf_currency_symbol
-
PE
-
PB
1.0077840933023179
ROE
-67.88395629840994
ROA
-48.37291296153684
FCF
-5171364
Fcf Percent
-8.210782025511808
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
4.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
629826
Quarters > 0 > income Statement > cost Of Revenue
534044
Quarters > 0 > income Statement > gross Profit
95782
Quarters > 0 > income Statement > operating Expenses
5695806
Quarters > 0 > income Statement > operating Income
-5600024
Quarters > 0 > income Statement > interest Expense
13908
Quarters > 0 > income Statement > pretax Income
-5366148
Quarters > 0 > income Statement > net Income
-5366148
Quarters > 0 > income Statement > eps
-0.004445735098887923
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1207032781
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5110036
Quarters > 0 > income Statement > operating Margin
-889.1382699348709
Quarters > 0 > income Statement > total Other Income Expense Net
233875
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
7290630
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
349395
Quarters > 0 > balance Sheet > inventories
2255260
Quarters > 0 > balance Sheet > total Current Assets
9895286
Quarters > 0 > balance Sheet > property Plant Equipment
612857
Quarters > 0 > balance Sheet > total Assets
11093291
Quarters > 0 > balance Sheet > payables
2499274
Quarters > 0 > balance Sheet > short Term Debt
135306
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3188407
Quarters > 0 > balance Sheet > equity
7904884
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5366148
Quarters > 0 > cash Flow > depreciation
242205
Quarters > 0 > cash Flow > change In Working Capital
-750913
Quarters > 0 > cash Flow > cash From Operations
-5130245
Quarters > 0 > cash Flow > capital Expenditures
41119
Quarters > 0 > cash Flow > cash From Investing
-41120
Quarters > 0 > cash Flow > cash From Financing
-80514
Quarters > 0 > cash Flow > net Change In Cash
-4808505
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.004445735098887923
Quarters > 0 > ratios > PB
1.0077840933023179
Quarters > 0 > ratios > ROE
-67.88395629840994
Quarters > 0 > ratios > ROA
-48.37291296153684
Quarters > 0 > ratios > FCF
-5171364
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-8.210782025511808
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1970020
Quarters > 1 > income Statement > cost Of Revenue
1129778
Quarters > 1 > income Statement > gross Profit
840242
Quarters > 1 > income Statement > operating Expenses
5568504
Quarters > 1 > income Statement > operating Income
-4728262
Quarters > 1 > income Statement > interest Expense
10667
Quarters > 1 > income Statement > pretax Income
-4527342
Quarters > 1 > income Statement > net Income
-4527342
Quarters > 1 > income Statement > eps
-0.0037273460947665985
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1214628823
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4331644
Quarters > 1 > income Statement > operating Margin
-240.01086283387986
Quarters > 1 > income Statement > total Other Income Expense Net
200920
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
12111708
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
364928
Quarters > 1 > balance Sheet > inventories
1428633
Quarters > 1 > balance Sheet > total Current Assets
14382503
Quarters > 1 > balance Sheet > property Plant Equipment
696020
Quarters > 1 > balance Sheet > total Assets
15792306
Quarters > 1 > balance Sheet > payables
595737
Quarters > 1 > balance Sheet > short Term Debt
258907
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3649701
Quarters > 1 > balance Sheet > equity
12142605
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4527342
Quarters > 1 > cash Flow > depreciation
511158
Quarters > 1 > cash Flow > change In Working Capital
260322
Quarters > 1 > cash Flow > cash From Operations
-3053686
Quarters > 1 > cash Flow > capital Expenditures
192654
Quarters > 1 > cash Flow > cash From Investing
30246
Quarters > 1 > cash Flow > cash From Financing
-69652
Quarters > 1 > cash Flow > net Change In Cash
-3119047
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0037273460947665985
Quarters > 1 > ratios > PB
0.6602001985405932
Quarters > 1 > ratios > ROE
-37.2847671484002
Quarters > 1 > ratios > ROA
-28.6680235299392
Quarters > 1 > ratios > FCF
-3246340
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.6478715952122314
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
985010
Quarters > 2 > income Statement > cost Of Revenue
564889
Quarters > 2 > income Statement > gross Profit
420121
Quarters > 2 > income Statement > operating Expenses
2784252
Quarters > 2 > income Statement > operating Income
-2364131
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2263671
Quarters > 2 > income Statement > net Income
-2263671
Quarters > 2 > income Statement > eps
-0.0018636730473832993
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1214628823
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2165822
Quarters > 2 > income Statement > operating Margin
-240.01086283387986
Quarters > 2 > income Statement > total Other Income Expense Net
100460
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
12111708
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
321855
Quarters > 2 > balance Sheet > inventories
1428633
Quarters > 2 > balance Sheet > total Current Assets
14382503
Quarters > 2 > balance Sheet > property Plant Equipment
696020
Quarters > 2 > balance Sheet > total Assets
15792306
Quarters > 2 > balance Sheet > payables
595737
Quarters > 2 > balance Sheet > short Term Debt
129521
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3649701
Quarters > 2 > balance Sheet > equity
12142605
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-2263671
Quarters > 2 > cash Flow > depreciation
255579
Quarters > 2 > cash Flow > change In Working Capital
130161
Quarters > 2 > cash Flow > cash From Operations
-1526843
Quarters > 2 > cash Flow > capital Expenditures
96327
Quarters > 2 > cash Flow > cash From Investing
15123
Quarters > 2 > cash Flow > cash From Financing
-34826
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0018636730473832993
Quarters > 2 > ratios > PB
0.6602001985405932
Quarters > 2 > ratios > ROE
-18.6423835742001
Quarters > 2 > ratios > ROA
-14.3340117649696
Quarters > 2 > ratios > FCF
-1623170
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.6478715952122314
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
1119938
Quarters > 3 > income Statement > cost Of Revenue
536890
Quarters > 3 > income Statement > gross Profit
583048
Quarters > 3 > income Statement > operating Expenses
4604118
Quarters > 3 > income Statement > operating Income
-4021070
Quarters > 3 > income Statement > interest Expense
5171
Quarters > 3 > income Statement > pretax Income
-4012628
Quarters > 3 > income Statement > net Income
-4012628
Quarters > 3 > income Statement > eps
-0.014186531334103008
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
282847717
Quarters > 3 > income Statement > income Tax Expense
1.84
Quarters > 3 > income Statement > EBITDA
-3567178
Quarters > 3 > income Statement > operating Margin
-359.04398279190457
Quarters > 3 > income Statement > total Other Income Expense Net
8442
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
15215775
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
529536
Quarters > 3 > balance Sheet > inventories
1977581
Quarters > 3 > balance Sheet > total Current Assets
17722892
Quarters > 3 > balance Sheet > property Plant Equipment
295602
Quarters > 3 > balance Sheet > total Assets
19054035
Quarters > 3 > balance Sheet > payables
2627568
Quarters > 3 > balance Sheet > short Term Debt
295357
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3236545
Quarters > 3 > balance Sheet > equity
15817490
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4012628
Quarters > 3 > cash Flow > depreciation
453892
Quarters > 3 > cash Flow > change In Working Capital
423824
Quarters > 3 > cash Flow > cash From Operations
-2554138
Quarters > 3 > cash Flow > capital Expenditures
4980
Quarters > 3 > cash Flow > cash From Investing
46958
Quarters > 3 > cash Flow > cash From Financing
11589644
Quarters > 3 > cash Flow > net Change In Cash
4522070
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.014186531334103008
Quarters > 3 > ratios > PB
0.11802093329599071
Quarters > 3 > ratios > ROE
-25.368298004297774
Quarters > 3 > ratios > ROA
-21.059203470550987
Quarters > 3 > ratios > FCF
-2559118
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.2850532797351284
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3089957
Annuals > 0 > income Statement > cost Of Revenue
1666667
Annuals > 0 > income Statement > gross Profit
1423290
Annuals > 0 > income Statement > operating Expenses
10172622
Annuals > 0 > income Statement > operating Income
-8749332
Annuals > 0 > income Statement > interest Expense
16178
Annuals > 0 > income Statement > pretax Income
-8539972
Annuals > 0 > income Statement > net Income
-8539972
Annuals > 0 > income Statement > eps
-0.007075178184410884
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1207032781
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7558742
Annuals > 0 > income Statement > operating Margin
-283.15384324118423
Annuals > 0 > income Statement > total Other Income Expense Net
209360
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
12111708
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
364928
Annuals > 0 > balance Sheet > inventories
1428633
Annuals > 0 > balance Sheet > total Current Assets
14382503
Annuals > 0 > balance Sheet > property Plant Equipment
696020
Annuals > 0 > balance Sheet > total Assets
15792306
Annuals > 0 > balance Sheet > payables
595737
Annuals > 0 > balance Sheet > short Term Debt
258907
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3649701
Annuals > 0 > balance Sheet > equity
12142605
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8539972
Annuals > 0 > cash Flow > depreciation
965052
Annuals > 0 > cash Flow > change In Working Capital
1462563
Annuals > 0 > cash Flow > cash From Operations
-5607823
Annuals > 0 > cash Flow > capital Expenditures
197634
Annuals > 0 > cash Flow > cash From Investing
77204
Annuals > 0 > cash Flow > cash From Financing
11519991
Annuals > 0 > cash Flow > net Change In Cash
5940072
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.007075178184410884
Annuals > 0 > ratios > PB
0.6560714405681483
Annuals > 0 > ratios > ROE
-70.33064157155734
Annuals > 0 > ratios > ROA
-54.07678903891553
Annuals > 0 > ratios > FCF
-5805457
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.8788148184586388
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
890933
Annuals > 1 > income Statement > cost Of Revenue
555450
Annuals > 1 > income Statement > gross Profit
335483
Annuals > 1 > income Statement > operating Expenses
12891646
Annuals > 1 > income Statement > operating Income
-12556163
Annuals > 1 > income Statement > interest Expense
15990
Annuals > 1 > income Statement > pretax Income
-11884803
Annuals > 1 > income Statement > net Income
-11884803
Annuals > 1 > income Statement > eps
-0.05546429372189043
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
214278452
Annuals > 1 > income Statement > income Tax Expense
1
Annuals > 1 > income Statement > EBITDA
-11194991
Annuals > 1 > income Statement > operating Margin
-1409.3274129479994
Annuals > 1 > income Statement > total Other Income Expense Net
671360
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6171636
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
369155
Annuals > 1 > balance Sheet > inventories
2221823
Annuals > 1 > balance Sheet > total Current Assets
9078576
Annuals > 1 > balance Sheet > property Plant Equipment
446756
Annuals > 1 > balance Sheet > total Assets
10882632
Annuals > 1 > balance Sheet > payables
323540
Annuals > 1 > balance Sheet > short Term Debt
283489
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2584188
Annuals > 1 > balance Sheet > equity
8298444
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-12171136
Annuals > 1 > cash Flow > depreciation
937197
Annuals > 1 > cash Flow > change In Working Capital
323773
Annuals > 1 > cash Flow > cash From Operations
-10434998
Annuals > 1 > cash Flow > capital Expenditures
78915
Annuals > 1 > cash Flow > cash From Investing
219984
Annuals > 1 > cash Flow > cash From Financing
-140042
Annuals > 1 > cash Flow > net Change In Cash
-10282605
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.05546429372189043
Annuals > 1 > ratios > PB
0.17042204336138198
Annuals > 1 > ratios > ROE
-143.21724651030965
Annuals > 1 > ratios > ROA
-109.20890277278512
Annuals > 1 > ratios > FCF
-10513913
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-11.801014217679668
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1033008
Annuals > 2 > income Statement > cost Of Revenue
684732
Annuals > 2 > income Statement > gross Profit
348276
Annuals > 2 > income Statement > operating Expenses
14018846
Annuals > 2 > income Statement > operating Income
-13670570
Annuals > 2 > income Statement > interest Expense
23762
Annuals > 2 > income Statement > pretax Income
-13905596
Annuals > 2 > income Statement > net Income
-13905596
Annuals > 2 > income Statement > eps
-0.0656082579313422
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
211948868
Annuals > 2 > income Statement > income Tax Expense
-211264
Annuals > 2 > income Statement > EBITDA
-12780857
Annuals > 2 > income Statement > operating Margin
-1323.3750367857751
Annuals > 2 > income Statement > total Other Income Expense Net
-235026
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
16454241
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
109397
Annuals > 2 > balance Sheet > inventories
1711419
Annuals > 2 > balance Sheet > total Current Assets
19825309
Annuals > 2 > balance Sheet > property Plant Equipment
692786
Annuals > 2 > balance Sheet > total Assets
22537225
Annuals > 2 > balance Sheet > payables
597363
Annuals > 2 > balance Sheet > short Term Debt
285060
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3232267
Annuals > 2 > balance Sheet > equity
19304958
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-13905596
Annuals > 2 > cash Flow > depreciation
1038241
Annuals > 2 > cash Flow > change In Working Capital
-833715
Annuals > 2 > cash Flow > cash From Operations
-12258031
Annuals > 2 > cash Flow > capital Expenditures
63946
Annuals > 2 > cash Flow > cash From Investing
-63946
Annuals > 2 > cash Flow > cash From Financing
147619
Annuals > 2 > cash Flow > net Change In Cash
-12420667
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.0656082579313422
Annuals > 2 > ratios > PB
0.07246130909997318
Annuals > 2 > ratios > ROE
-72.0312160223296
Annuals > 2 > ratios > ROA
-61.70056872574152
Annuals > 2 > ratios > FCF
-12321977
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-11.928249345600422
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1185427
Annuals > 3 > income Statement > cost Of Revenue
677402
Annuals > 3 > income Statement > gross Profit
508025
Annuals > 3 > income Statement > operating Expenses
14824472
Annuals > 3 > income Statement > operating Income
-14316447
Annuals > 3 > income Statement > interest Expense
21101
Annuals > 3 > income Statement > pretax Income
-14016004
Annuals > 3 > income Statement > net Income
-14016004
Annuals > 3 > income Statement > eps
-0.07116121720455565
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
196961274
Annuals > 3 > income Statement > income Tax Expense
1
Annuals > 3 > income Statement > EBITDA
-13522247
Annuals > 3 > income Statement > operating Margin
-1207.7038063077691
Annuals > 3 > income Statement > total Other Income Expense Net
300443
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
28874908
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
119096
Annuals > 3 > balance Sheet > inventories
1426810
Annuals > 3 > balance Sheet > total Current Assets
31272686
Annuals > 3 > balance Sheet > property Plant Equipment
1057595
Annuals > 3 > balance Sheet > total Assets
34529663
Annuals > 3 > balance Sheet > payables
405953
Annuals > 3 > balance Sheet > short Term Debt
22169
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2791641
Annuals > 3 > balance Sheet > equity
31738022
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-14016004
Annuals > 3 > cash Flow > depreciation
934364
Annuals > 3 > cash Flow > change In Working Capital
-695516
Annuals > 3 > cash Flow > cash From Operations
-12250467
Annuals > 3 > cash Flow > capital Expenditures
541454
Annuals > 3 > cash Flow > cash From Investing
-541454
Annuals > 3 > cash Flow > cash From Financing
35065207
Annuals > 3 > cash Flow > net Change In Cash
22592243
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.07116121720455565
Annuals > 3 > ratios > PB
0.04095858300180144
Annuals > 3 > ratios > ROE
-44.16155486942444
Annuals > 3 > ratios > ROA
-40.59119835603377
Annuals > 3 > ratios > FCF
-12791921
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-10.790981646275982
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.004445735098887923
Valuation > metrics > PB
1.0077840933023179
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-67.88395629840994
Profitability > metrics > ROA
-54.229337080302685
Profitability > metrics > Net Margin
-8.520048394318431
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.40334646276909314
Risk > metrics > Interest Coverage
-402.64768478573484
Risk > final Score
-1551
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.755925422648012
Liquidity > metrics > Quick Ratio
2.8999028308117425
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1713
Prev Risks > 1
-37
Prev Risks > 2
-3050
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:24:09.080Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-06
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0132
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0132
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0132
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0132
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0103
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0103
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0103
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0103
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0116
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0116
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0116
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0116
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.012
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.012
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.012
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.012
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0168
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0168
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0168
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0168
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0145
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0145
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0145
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0145
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0287
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0287
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0287
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0287
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0387
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0387
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0387
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0387
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0309
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0309
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0309
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0309
Earnings History > 18 > surprise Percent
-
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APolarean shares jump 12% after Philips clears its Xenon lung-scan tech - Proactive Investors
12/1/2025
Polarean shares jump 12% after Philips clears its Xenon lung-scan tech Proactive Investors
Read more →Market movers: Charbone Hydrogen, Moderna, Synopsys... Proactive financial news
Read more →Showing 2 of 5
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Polarean Imaging plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0132
EPS Estimate
0
EPS Difference
-0.0132
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.